Recently, at the inaugural Africa Digital Pathology Congress, Wuhan Landing Intelligence Medical Co., Ltd. (hereinafter referred to as Landing Med) became a focal point with its independently developed AI-powered digital pathology solution—highlighting the breakthrough value of Chinese innovation in global medical technology.
During the congress, Ms. Wang Lan, International Market Director at Landing Med, shared the company's successful experience in China, where its solutions have significantly eased the burden on primary healthcare systems. The congress chair, Dr. Hicham El Attar, spoke highly of Landing Med's technology, stating:"Landing Med offers an affordable and sustainable solution for African healthcare. It deserves to be promoted across the continent".
On April 18, Ms. Wang Lan (left) and Dr. Hicham El Attar (right), chair of the first Africa Digital Pathology Congress, pictured in front of the Landing Med booth. The company's digital pathology system, including the all-in-one portable digital pathology slide scanner and the high throughput cytology slide scanner, was the only physical product displayed at the booth and drew significant attention.
In the African market, Landing Med continues to demonstrate strong technological adaptability. Its AI-powered cancer screening solution for underserved regions has garnered widespread interest, offering practical and scalable support to areas with limited healthcare resources. As successful implementations in countries like Pakistan and Morocco continue to grow, Landing Med is transforming Chinese innovation into a global public health asset. From the banks of the Yangtze River to the edges of the Sahara, Landing Med's technological footprint is helping to write a new chapter in the global fight against cancer.
Popular Search Terms from Landing Med
fr 
es 
CN
